(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ELAFIBRANOR PARA O TRATAMENTO DE COLANGITE ESCLEROSANTE PRIMÁRIA

Em ExigênciaInvention PatentPCT · EP2021063075

Application data

Number

112022023368

Type

Invention Patent

Filing

05/18/2021

Publication

12/20/2022

PCT

EP2021063075

Progress at the INPI

Technical opinion to answer
  1. Filing05/18/21
  2. Publication12/20/22
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 05/12/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

GENFIT

FR

See this company's full portfolio

Inventors

A. R. (pessoa física)

FR

Technical data

IPC Classification

Priority claims

EP

20305513.2 · 05/18/2020

Abstract

ELAFIBRANOR PARA O TRATAMENTO DE COLANGITE ESCLEROSANTE PRIMÁRIA.A presente invenção se refere a elafibranor ou seu metabólito ativo para uso em um método de tratamento de colangite esclerosante primária.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

05/12/2026

RPI 2888

Notificação de entrada na fase nacional - PCT

#1.3

12/20/2022

RPI 2711

Alteração de dados cadastrais

#1.1

11/29/2022

RPI 2708

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.